APRIL 29, 2022

US-based Biotechnology company, Taiga launches breakthrough veterinary cancer treatment in Singapore

AURORA, Colo., and SINGAPORE, Singapore -- Taiga Biotechnologies, a clinical-stage biotechnology company focused on harnessing the power of the immune system to fight solid tumors and infectious disease, announced today the introduction of an easy-to-use, cost-effective product, which will be offered by SustentoBio Inc., a 100% owned subsidiary of Taiga Biotechnologies, Inc. represents a significant development in immunotherapies for veterinary use for treatment of solid tumour cancers and aging.  [...]